-
公开(公告)号:US20250064100A1
公开(公告)日:2025-02-27
申请号:US18918621
申请日:2024-10-17
Applicant: SOCIETE DES PRODUITS NESTLE S.A.
Inventor: JEROME FEIGE , ELIZABETH FORBES-BLOM , JORIS MICHAUD , AMAURY PATIN , CLAIRE BOUTRY , PASCAL STUELSATZ
IPC: A23L29/00 , A23L33/115 , A61K31/22 , A61K31/231 , A61P21/00 , A61P43/00 , C11C3/00 , C11C3/10
Abstract: A compound having the formula or combinations thereof, for use to maintain or increase muscle function and/or mass in a subject, and/or prevent or reduce muscle wasting in a subject, wherein R1, R2, R3, R4, R5 and R6 are independently, a long chain fatty acid having between 16 and 20 carbons.
-
公开(公告)号:US20250049086A1
公开(公告)日:2025-02-13
申请号:US18933112
申请日:2024-10-31
Applicant: MIZKAN HOLDINGS CO., LTD.
Inventor: Manabu Konishi , Junichiro Ihara
Abstract: A method for easily controlling the smell of dried starch and bringing out a sweet starch flavor characteristic of a plant in a powdery food containing a powder derived from a starch-containing plant is provided. A powdery food comprises a powder derived from a starch-containing plant. The powdery food has a starch content of 10 mass % or more in terms of dry mass, a dietary fiber content of 1 mass % or more in terms of dry mass, a particle size d50 of 1,000 μm or less after ultrasonication, and a 2,3-butanediol content of 50 ppb or more and 40,000 ppb or less and/or a diethylene glycol monoethyl ether content of 5 ppb or more and 40,000 ppb or less.
-
公开(公告)号:US20250040577A1
公开(公告)日:2025-02-06
申请号:US18722527
申请日:2022-12-20
Applicant: CJ CHEILJEDANG CORPORATION
Inventor: Hee Jeung KIM , Seoyoon JEONG , Hongwook PARK , Ki Moon KANG
Abstract: The present disclosure relates to a coagulant for producing a bean curd, a bean curd produced using the coagulant, and a method of producing a bean curd using the coagulant.
-
公开(公告)号:US20250000037A1
公开(公告)日:2025-01-02
申请号:US18882639
申请日:2024-09-11
Applicant: david alan heldreth, JR.
Inventor: david alan heldreth, JR.
IPC: A01G22/15 , A01C7/00 , A01D45/06 , A23L2/52 , A23L29/00 , A24B15/16 , A24B15/167 , A61K36/185 , C12G3/04
Abstract: This present invention is directed to a method for the production and use of the leaf and/or leaves and/or stem(s) and/or stalk(s) of plants of the cannabis species for animal, microbial, bacteria, fungi or human consumption as a food, supplement, medicine, beverage.
-
公开(公告)号:US12161666B2
公开(公告)日:2024-12-10
申请号:US18110581
申请日:2023-02-16
Applicant: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Abstract: Compositions contain an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to promote a swallowing reflex. The composition containing the combination of cinnamaldehyde and zinc can be used in a method to treat dysphagia and/or prevent aspiration pneumonia from dysphagia. In an embodiment, the composition containing cinnamaldehyde is administered to a human. The composition containing cinnamaldehyde may be a medicament, a food product or a supplement to a food product.
-
公开(公告)号:US20240397973A1
公开(公告)日:2024-12-05
申请号:US18256056
申请日:2021-12-29
Applicant: Conopco Inc., d/b/a UNILEVER
Inventor: Marianne DRIESSE , Shar Margriet PIJPERS
Abstract: The present invention relates to an improved meat analogue and process to produce the same.
-
公开(公告)号:US12144364B2
公开(公告)日:2024-11-19
申请号:US17222300
申请日:2021-04-05
Applicant: Goli Nutrition Inc.
Inventor: Michael Bitensky , Nicol Korner-Bitensky , Olivia Joan Dahm , Roger Arthur Tyre , Sharon Hoffman , Deepak Agarwal
IPC: A23L33/105 , A23L2/68 , A23L29/00 , A23L29/231
Abstract: Shown herein is a nutritional supplement containing apple cider vinegar (ACV), including compositions, formulations, and combinations of ingredients in the ACV nutritional supplement, as well as processes for manufacturing these supplements. The nutritional supplement can include ACV, a gelling agent such as pectin or gelatin, an oligosaccharide, a disaccharide, and water.
-
公开(公告)号:US20240373895A1
公开(公告)日:2024-11-14
申请号:US18542529
申请日:2023-12-15
Applicant: Bragg Live Food Products, LLC
Inventor: Louis Izuchukwu Ndife , Jones Yiu Chung Chan , Jose Emilio Villarreal , Diane Humphrey Kull
IPC: A23L33/105 , A23L29/00 , A23L33/155
Abstract: There is disclosed a novel method for introducing non-GMO acetate to the human body.
-
公开(公告)号:US12138226B2
公开(公告)日:2024-11-12
申请号:US17853159
申请日:2022-06-29
Applicant: Alcresta Therapeutics, Inc.
Inventor: Alexey L. Margolin , Robert Gallotto , Bhami Shenoy
IPC: A23L33/00 , A23D7/00 , A23D7/01 , A23D9/013 , A23K20/158 , A23K50/30 , A23L29/00 , A23L33/115 , A23L33/12 , A61J15/00 , A61K9/00 , A61K31/202 , A61K38/46 , B65D1/02 , B65D41/02 , B65D81/32 , B65D85/72
Abstract: Nutritional formulas comprising long-chain polyunsaturated fatty acids (LC-PUFAs) are provided, along with methods and devices for preparing and/or administering nutritional formulas. In some embodiments, a percentage of the LC-PUFAs in the nutritional formula are in the form of monoglycerides and/or free fatty acids. In some embodiments, the nutritional formulas do not comprise added lipase. Also provided are methods for providing nutrition to a subject, methods for improving fat absorption, methods for improving cognitive ability, methods for preventing chronic lung disease, and methods for reducing the length of time a patient requires total parenteral nutrition.
-
公开(公告)号:US12133873B2
公开(公告)日:2024-11-05
申请号:US17433427
申请日:2020-02-27
Applicant: KOREA FOOD RESEARCH INSTITUTE
Inventor: Hak-Jong Choi , Seul-Ki Lim
IPC: A61K35/744 , A23L29/00 , A61P1/16
Abstract: The present invention relates to novel Leuconostoc citreum WiKim0104 isolated from Kimchi and a composition comprising the same or its use. The present invention provides a method for prevention, improvement and treatment of inflammation, obesity or fatty liver disease of a subject by administering the novel Leuconostoc citreum WiKim0104 isolated from Kimchi or a composition comprising thereof. The Leuconostoc citreum WiKim0104 according to the present invention shows an inhibitory effect for fatty liver production by inhibiting fat accumulation in liver cells and reducing expression of fatty liver-related genes, and thus it may be variously utilized for uses in prevention, improvement and treatment of inflammation, obesity or fatty liver disease.
-
-
-
-
-
-
-
-
-